MPM Capital is a venture capital firm founded in 1996. The firm was founded by Luke Evnin and Ansbert Gadicke. It is primarily based in Cambridge, Massachusetts although it also has offices in Brisbane, California and Kansas City, Kansas. As of March 2019, the firm is managing 33 active companies in its portfolio and has sold off its ownership in 199 companies. Its most recent investment was in Harpoon Therapeutics on November 2018, a company developing clinical-stage immunotherapy .
MPM Capital specializes in funding life sciences and healthcare companies. It provides financing at various stages of development, from seed to buyout. The firm invests on companies worldwide, but it prioritizes funding companies that are based in the United States, Europe, and India. Since its establishment, the firm has managed to amass a total fund of $2.9 billion across ten funding series. Its most recent funding round was held in February 2019 which collected $400 million.
A biotechnology company that develops treatments for cancer and hematologic conditions
A biotechnology company based in Mountain View, California providing DNA genetic testing and analysis services.
A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.
TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
A pharmaceutical company developing oral therapies for chronic diseases.
EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Nevro is a Menlo Park, California-based biotechnology company.
A biopharmaceutical company developing therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders
A company developing therapeutics for veterinary medicine
A life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests
A biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease
A company developing drug therapies for osteoporosis and women’s health
A biodefense company developing medical countermeasures against threats of biological and chemical weapons
A company developing technologies in protein-based therapeutics
A company focused on the discovery and development of therapies for neurodegenerative diseases
A biotechnology company that develops therapeutic antibodies for treating infectious diseases and inflammation
A biopharmaceutical company that develops therapeutics to treat cancer
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors
A company focused on development and manufacture of products for endovascular aortic repair
A company developing treatments for liver and other chronic dieases
A pharmaceutical company focused developing products for pain management and women’s healthcare
Nested is a London-based company.
A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
A company developing oral protein therapeutics to treat metabolic diseases
Associated investment funds
Chief Financial Officer
Chief Operating Officer
Documentaries, videos and podcasts